Navigation Links
Quest Diagnostics Chooses Roche's Fully Automated, Real-Time HIV-1 Viral Load Monitoring Test For Its Customers in Laboratories Nationwide
Date:5/19/2008

INDIANAPOLIS, May 19 /PRNewswire/ -- Roche Diagnostics today announced that Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, has signed a multi-year agreement to use the COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HIV-1 Test for HIV viral load testing.

Physicians use the test information to monitor the effects of antiretroviral therapy by measuring changes in HIV-1 RNA levels. Roche's newest HIV-1 viral load monitoring test is the first fully automated real-time PCR test approved by the Food and Drug Administration.

"We are pleased to continue what has been a strong partnership since Quest Diagnostics first began using our molecular HIV test 12 years ago," said Whitney Green, Senior Vice-President for Molecular Diagnostics of Roche Diagnostics. "We share Quest Diagnostics' commitment to its physicians who need the most accurate testing information to make the best treatment decisions for their patients."

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2007, sales by the Pharmaceuticals Division totale
'/>"/>

SOURCE Roche Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Quest Diagnostics Is Named Best Employer For Healthy Lifestyles
2. $3 Million Requested by UNFPA to Help Women and Girls Displaced by Myanmar Cyclone
3. Aspen Institute to Release Presidential Candidates Responses to Health Care Reform Questionnaire; New Zogby Poll Findings Also to be Released
4. Study raises questions about prostate cancer therapies targeting IGF-1
5. Moral philosopher questions memory manipulation
6. Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
7. Vioxx Disclosure Emphasizes Need for New Web Resource that Answers Questions About Anti-Epileptic Medication Use
8. Susan G. Komen for the Cure Advocacy Alliance Suggests Questions for Tonights Presidential Debate
9. ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
10. Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call
11. New conference tackles the tough questions in lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... estimated 29,000 future cancers could be linked to scans performed ... Commonly performed CT scans are exposing patients to far more ... tens of thousands of cancers a year, two new studies ... 14/28 issue of the Archives of Internal Medicine , ... Rita F. Redberg, are calling on clinicians to limit radiation ...
(Date:12/14/2009)... finds, , , MONDAY, Dec. 14 (HealthDay News) -- Here,s ... without a cup or two of java: Coffee and ... 2 diabetes. , That,s the conclusion of an ... drink, the lower your risk of diabetes. Every cup ... in the risk of diabetes, the researchers said. ...
(Date:12/14/2009)... Type 2 diabetes and obesity are linked to an ... suggested that insulin glargine (a synthetic insulin preparation marketed ... a higher risk of certain cancers than other insulins ... were unable to control for important factors such as ... On the other hand, a large randomized trial designed ...
(Date:12/14/2009)... might lead to better treatments for asthma, COPD, researchers ... have identified five genetic variants that influence lung function, ... for lung diseases. , The international team of researchers ... the 2.5 million sites across the human genome in ... the team to the five common genetic variants associated ...
(Date:12/14/2009)... rates for meth and smoking, but concerns about ... News) -- Fewer teenagers are using methamphetamine, but ... of prescription drugs remains high, U.S. health officials ... drugs, such as the hallucinogenic salvia leaf and ... treatment of attention-deficit hyperactivity disorder (ADHD), appear to ...
Breaking Medicine News(10 mins):Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4
... average of 80 die each year while trimming trees , , ... an average of 80 tree-care workers died annually in the ... training programs in this industry. , Almost half of the ... causes of these deaths included being struck by tree branches ...
... genetic manipulation poses, study finds , , THURSDAY, April 23 ... embryonic-like stem cells by using chemical programming instead of ... that has posed the risk of serious health problems ... to make stem cells without genetically altering them could ...
... nodules is high and there are certain ultrasound features, ... not a biopsy is needed, according to a study ... Center, San Francisco, CA. , A total of ... no cancer) were analyzed. "Our study supports previous data ...
... may offer radiologists a fun, alternative method to using a ... to a study performed at the New-York Presbyterian Hospital/Weill Cornell ... offer radiologists relief from repetitive motion injuries as a result ... "We have developed a new fun and exciting way for ...
... with a high degree of confidence, whether or not ... removed through polypectomy, according to a study performed at ... Health in Madison, WI. , The study included ... "In our study, we found that when a clinically ...
... Diffusion weighted MR can accurately identify benign from malignant ... to a study performed at Massachusetts General Hospital in ... that uses an MRI sequence sensitized to the motion ... imaging with CT or MRI uses the size of ...
Other Medicine News:Health News:Scientists Find New Way to Create Stem Cells 2Health News:Popular gaming system may offer radiologists an alternative way to view patient images 2Health News:Non-invasive test accurately identifies gynecologic malignancies 2
(Date:12/14/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced ... the addition of Lt. Gen. Ronald R. Blanck, DO, ... Blanck & Associates, a federal health services consulting firm ... company board now has nine members. ,, Dr. Blanck ... officer and battalion surgeon in Vietnam. He retired 32 ...
(Date:12/14/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... to help maintain the bone health of prostate ... therapy (ADT). Nearly two million men are ... that, while highly effective and considered the "gold ... man,s risk for osteoporosis. ,, As part of ...
(Date:12/14/2009)... DOVER, Del., Dec. 14 Ohr Pharmaceutical Inc. ... selected Allen & Caron Inc, headquartered in Irvine, ... London, as its agency for investor relations and ... stage biotechnology company focused on developing advanced drugs ... pipeline compounds with potentially large, global markets: OHR/AVR118 ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Expands Board of Directors 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 2Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 3SPECT provides high quality images of small tumors 48912 1Pregnant women at high risk of complications from H1N1 influenza 48908 1Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 1Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 2Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 3Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 4
... Israel, February 4 Oramed,Pharmaceuticals, Inc. (OTCBB: ORMP.OB), ... that it has concluded a proof of concept,study ... its,proprietary technology. Eight healthy volunteers came for two ... The insulin suppositories showed rapid insulin absorption ...
... PDUFA Date for Cinryze for Acute HAE Indication is June ... ViroPharma Incorporated (Nasdaq: VPHM ) today announced ... priority review for Cinryze C1 Inhibitor (human) as a treatment ... Biologics License Application (sBLA), submitted to the FDA on December ...
Other Medicine Technology:Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6
Universal, clear, lightweight plastic with smooth edges & ventilation holes for patient comfort...
... exercise BP monitor is designed to automatically ... diastolic BP along with heart rate. It's ... use in treadmill, ergometer and pharmacological stress ... use in research environments., ,Tango excels ...
...
... TraceMasterVue is a cutting-edge ECG ... thin-client functionality and convenient, web-based ... administrative and information technology (IT) ... lower costs, and improved patient ...
Medicine Products: